AAAAAA
Results: 1-25/37
Authors:
Nicolas, L
Monneret, G
Debard, AL
Blesius, A
Gutowski, MC
Salles, G
Bienvenu, J
Citation: L. Nicolas et al., Human gamma delta T cells express a higher TCR/CD3 complex density than alpha beta T cells, CLIN IMMUNO, 98(3), 2001, pp. 358-363
Authors:
Seve, P
Thieblemont, C
Dumontet, C
Bouafia, F
Arnaud, P
Hequest, O
Espinouse, D
Salles, G
Coiffier, B
Citation: P. Seve et al., Skin lesions in malignancy case 3. Yellow nail syndrome in non-Hodgkin's lymphoma (vol 19, pg 2100, 2001), J CL ONCOL, 19(11), 2001, pp. 2972-2972
Authors:
Baseggio, L
Charlot, C
Picollet, J
Bienvenu, J
Salles, G
Citation: L. Baseggio et al., High circulating tumor necrosis factor levels correlate with increased levels of soluble CD14 in patients with non-Hodgkin's lymphoma, HAEMATOLOG, 86(7), 2001, pp. 774-775
Authors:
Baseggio, L
Bienvenu, J
Charlot, C
Picollet, J
Felman, P
Coiffier, B
Salles, G
Citation: L. Baseggio et al., Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients, EXP HEMATOL, 29(3), 2001, pp. 330-338
Authors:
Cardoso, C
Salles, G
Bloch, K
Deccache, W
Siqueira, AG
Citation: C. Cardoso et al., Clinical determinants of increased QT dispersion in patients with diabetesmellitus, INT J CARD, 79(2-3), 2001, pp. 253-262
Authors:
Dumontet, C
Morschhauser, F
Solal-Celigny, P
Bouafia, F
Bourgeois, E
Thieblemont, C
Leleu, X
Hequet, O
Salles, G
Coiffier, B
Citation: C. Dumontet et al., Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma, BR J HAEM, 113(3), 2001, pp. 772-778
Authors:
Dumontet, C
Drai, J
Thieblemont, C
Hequet, O
Espinouse, D
Bouafia, F
Salles, G
Coiffier, B
Citation: C. Dumontet et al., The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide, BR J HAEM, 112(2), 2001, pp. 405-409
Authors:
Colombat, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Delwail, V
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoullas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Thieblemont, C
Montestruc, F
Mathieu-Boue, A
Benzohra, A
Solal-Celigny, P
Citation: P. Colombat et al., Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy forpatients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation, BLOOD, 97(1), 2001, pp. 101-106
Authors:
Dumontet, C
Thieblemont, C
Espinouse, D
Bouafia, F
Hequet, O
Salles, G
Coiffier, B
Citation: C. Dumontet et al., A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors, LEUKEMIA, 14(12), 2000, pp. 2159-2165
Authors:
Salles, G
Filippetti, F
Tassoni, C
Grellet, G
Franceschini, G
Citation: G. Salles et al., Monitoring of induction motor load by neural network techniques, IEEE POW E, 15(4), 2000, pp. 762-768
Authors:
Steve, P
Thieblemont, C
Dumontet, C
Bouafia, F
Arnaud, P
Hequet, O
Espinouse, D
Salles, G
Coiffer, B
Citation: P. Steve et al., Skin lesions in malignancy case 3. Yellow nail syndrome in non-Hodgkin's lymphoma, J CL ONCOL, 19(7), 2000, pp. 2100-2101
Authors:
Voog, E
Bienvenu, J
Warzocha, K
Moullet, I
Dumontet, C
Thieblemont, C
Monneret, G
Gutowski, MC
Coiffier, B
Salles, G
Citation: E. Voog et al., Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: Role of the tumor necrosis factor ligand-receptor system, J CL ONCOL, 18(2), 2000, pp. 325-331
Authors:
Haioun, C
Lepage, E
Gisselbrecht, C
Salles, G
Coiffier, B
Brice, P
Bosly, A
Morel, P
Nouvel, C
Tilly, H
Lederlin, P
Sebban, C
Briere, J
Gaulard, P
Reyes, F
Citation: C. Haioun et al., Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study, J CL ONCOL, 18(16), 2000, pp. 3025-3030
Authors:
Warzocha, K
Ribeiro, P
Renard, N
Bienvenu, J
Charlot, C
Coiffier, B
Salles, G
Citation: K. Warzocha et al., Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas, CANCER IMMU, 49(9), 2000, pp. 469-475
Authors:
Michallet, M
Philip, T
Philip, I
Godinot, H
Sebban, C
Salles, G
Thiebaut, A
Biron, P
Lopez, F
Mazars, P
Roubi, N
Leemhuis, T
Hanania, E
Reading, C
Fine, G
Atkinson, K
Juttner, C
Coiffier, B
Fiere, D
Archimbaud, E
Citation: M. Michallet et al., Transplantation with selected autologous peripheral blood CD34(+)Thy1(+) hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution, EXP HEMATOL, 28(7), 2000, pp. 858-870
Authors:
Adida, C
Haioun, C
Gaulard, P
Lepage, E
Morel, P
Briere, J
Dombret, H
Reyes, F
Diebold, J
Gisselbrecht, C
Salles, G
Altieri, DC
Molina, TJ
Citation: C. Adida et al., Prognostic significance of survivin expression in diffuse large B-cell lymphomas, BLOOD, 96(5), 2000, pp. 1921-1925
Authors:
Berger, F
Felman, P
Thieblemont, C
Pradier, T
Baseggio, L
Bryon, PA
Salles, G
Callet-Bauchu, E
Coiffier, B
Citation: F. Berger et al., Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients, BLOOD, 95(6), 2000, pp. 1950-1956
Authors:
Thieblemont, C
Berger, F
Dumontet, C
Moullet, I
Bouafia, F
Felman, P
Salles, G
Coiffier, B
Citation: C. Thieblemont et al., Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed, BLOOD, 95(3), 2000, pp. 802-806
Authors:
Mounier, N
Haioun, C
Cole, BF
Gisselbrecht, C
Sebban, C
Morel, P
Marit, G
Bouabdallah, R
Ravoet, C
Salles, G
Reyes, F
Lepage, E
Citation: N. Mounier et al., Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission, BLOOD, 95(12), 2000, pp. 3687-3692
Authors:
Zhang, QG
Siebert, R
Yan, MH
Hinzmann, B
Cui, XL
Xue, LQ
Rakestraw, KM
Naeve, CW
Beckmann, G
Weisenburger, DD
Sanger, WG
Nowotny, H
Vesely, M
Callet-Bauchu, E
Salles, G
Dixit, VM
Rosenthal, A
Schlegelberger, B
Morris, SW
Citation: Qg. Zhang et al., Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32), NAT GENET, 22(1), 1999, pp. 63-68
Authors:
Callet-Bauchu, E
Gazzo, S
Poncet, C
Pages, J
Morel, D
Alliot, C
Coiffier, B
Coeur, P
Salles, G
Felman, P
Citation: E. Callet-bauchu et al., Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis, GENE CHROM, 26(3), 1999, pp. 221-228
Authors:
Renard, N
Ribeiro, P
Warzocha, K
Rouviere, R
Charlot, C
Coiffier, B
Salles, G
Citation: N. Renard et al., Modulation of costimulatory molecules on follicular lymphoma cells by TNF and CD40, LEUK LYMPH, 33(3-4), 1999, pp. 331-341
Authors:
Salles, G
Coiffier, B
Citation: G. Salles et B. Coiffier, Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma, BAIL CLIN H, 12(1-2), 1999, pp. 151-169
Authors:
Johnson, PWM
Swinbank, K
MacLennan, S
Colomer, D
Debuire, B
Diss, T
Gabert, J
Gupta, RK
Haynes, A
Kneba, M
Lee, MS
Macintyre, E
Mensink, E
Moos, M
Morgan, GJ
Neri, A
Johnson, A
Reato, G
Salles, G
van 't Veer, MB
Zehnder, JL
Zucca, E
Selby, PJ
Cotter, FE
Citation: Pwm. Johnson et al., Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study, ANN ONCOL, 10(11), 1999, pp. 1349-1354
Authors:
Shipp, MA
Abeloff, MD
Antman, KH
Carroll, G
Hagenbeek, A
Loeffler, M
Montserrat, E
Radford, JA
Salles, G
Schmitz, N
Symann, M
Armitage, JO
Coiffier, B
Philip, T
Citation: Ma. Shipp et al., International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury, ANN ONCOL, 10(1), 1999, pp. 13-19